Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-08-16
    E.g., 2018-08-16

Articles

Pages

1379 items
11:55 AM, Aug 10, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Sensyne proposes London IPO

Data analysis company Sensyne Health Ltd. (Oxford, U.K.) proposed to raise £60 million ($78 million) in an IPO on the London Stock Exchange's AIM market. The company expects to begin trading on Aug. 17. Sensyne uses...
11:30 PM, Aug 09, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Shanghai Junshi planning Hong Kong IPO

Shanghai Junshi Biosciences Co. Ltd. (Shanghai, China) proposed on Aug. 6 to list on Hong Kong Exchanges and Clearing Ltd. (HKEX) in an IPO. On Aug. 1, Ascletis Pharma Inc. (HKSE:1672) became the first biotech to...
11:17 AM, Jul 27, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

CRO Viva Biotech proposes HKEX listing

Viva Biotech Holdings (Shanghai, China) proposed to list on Hong Kong Exchanges and Clearing Ltd. (HKEX). In addition to the traditional cash-for-service model, the CRO plans to incubate 12 early stage R&D projects per year with...
10:32 AM, Jul 20, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Aquestive sets terms for proposed IPO

CNS disease company Aquestive Therapeutics Inc. (Warren, N.J.) revealed terms for its proposed IPO on NASDAQ. In a regulatory filing from July 16, the company proposed to sell 4 million shares at $14-$16. At the $15...
9:56 AM, Jul 20, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Roivant’s urology subsidiary files for $150M IPO

Urovant Sciences Ltd. (London, U.K) proposed on July 13 to raise up to $150 million in an IPO on NASDAQ underwritten by J.P. Morgan, Jefferies and Cowen. The urology play is a wholly owned subsidiary...
9:38 AM, Jul 20, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

CanSino latest to file for HKEX IPO

Vaccines company CanSino Biologics Inc. (Tianjin, China) on July 17 proposed to list on Hong Kong Exchanges and Clearing Ltd. (HKEX) in an IPO underwritten by Morgan Stanley and CLSA. CanSino said in its prospectus that...
9:36 AM, Jul 20, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Aridis proposes $34.5M IPO

Infectious disease company Aridis Pharmaceuticals Inc. (San Jose, Calif.) proposed on July 18 to raise $34.5 million in an IPO on NASDAQ underwritten by Cantor, Maxim Group and Northland Capital Markets. The company's lead candidate Salvecin...
12:59 PM, Jul 13, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Stealth, AOBiome propose Hong Kong offerings

Stealth BioTherapeutics Corp. (Newton, Mass.) and AOBiome Therapeutics Inc. (Cambridge, Mass.) each proposed on July 3 to list on Hong Kong Exchanges and Clearing Ltd. (HKEX). Stealth’s lead candidate is elamipretide, a mitochondrial-targeting tetrapeptide that binds...
2:18 PM, Jun 29, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Crinetics proposes $86.3M IPO

Endocrine disease company Crinetics Pharmaceuticals Inc. (San Diego, Calif.) proposed on June 22 to raise up to $86.3 million in an IPO on NASDAQ underwritten by J.P. Morgan, Leerink and Piper Jaffray. In March, Crinetics raised...
12:32 PM, Jun 15, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Autolus proposes IPO terms

Cell therapy developer Autolus Therapeutics Ltd. (London, U.K.) revealed terms for its proposed IPO on NASDAQ. In a regulatory filing June 8, the company proposed to sell 7.8 million ADSs at $15-$17, with each ADS...

Pages